Home Press Releases Infusion Pump Market: Growing adoption of specialty infusion systems

Infusion Pump Market: Growing adoption of specialty infusion systems

by Press Room


 


(EMAILWIRE.COM, March 20, 2023 )

The adoption of several specialty infusion pumps is on the rise globally. Patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, and implantable infusion pumps are the different types of specialty infusion pumps available in the market. PCA pumps induce anesthesia in a controlled manner and reduce the complications associated with anesthetics. These pumps are also widely used for pain management during labor pain and chronic diseases. Enteral infusion pumps are imperative medical tools for patients who face difficulties caused by indigestion due to recent surgeries or functional inabilities of various digestive organs. The increasing incidence of preterm births, the shift from parenteral to enteral nutrition, and the rising prevalence of chronic diseases have increased the adoption of enteral infusion pumps.

The global Infusion pumps market is projected to reach USD 20.5 billion by 2027, at a CAGR of 7.0 % during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506

Market Segmentation:

The accessories & consumables segment is estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the recurrent use of accessories & consumables and the increasing adoption of infusion pumps for the delivery of medications in a controlled environment.

Based on application the chemotherapy/oncology application segment accounted for the largest share of the market in 2020. The large share of this segment can be attributed to the growing incidence of cancer, increasing availability of ambulatory infusion pumps for chemotherapy, and the introduction of technologically advanced products in the market.

Based on setting, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic & research institutes. The home care setting segment accounted for the largest share of the market in 2020. Chronic diseases, such as cancer and diabetes, require continuous monitoring and treatment. Ambulatory infusion pumps for chronic disease management enable patients to remain mobile during therapy sessions. Therefore, the use of ambulatory insulin pumps in the home and alternate care segments has increased in the recent past.

Regional Analysis

Geographically, the infusion pumps market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market, followed by Europe and the APAC. The large share of North America can primarily be attributed to the high adoption of specialty infusion pumps for the treatment of chronic diseases, increasing prevalence of chronic diseases, rising geriatric population, and the presence of many large hospitals in the region. Moreover, a large number of major global players are based in the US, owing to which the US is a center for innovation in the market.

Request for Sample Pages: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506

Top Key Players:
The infusion pumps market is dominated by Becton, Dickinson and Company (US), Baxter International Inc. (US), B. Braun (Germany), Smiths Medical (US), Fresenius Kabi (Germany), and ICU Medical, Inc. (US). These players adopted major growth strategies such as product launches & approvals, collaborations, and expansions. Other prominent players in the market include Terumo Corporation (Japan), Nipro Corporation (Japan), Avanos Medical, Inc. (US), Tandem Diabetes Care, Inc. (US), JMS Co., Ltd. (Japan), Insulet Corporation (US), Roche Diagnostics (Switzerland), Zyno Medical (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), Ypsomed Holding AG (Switzerland), InfuTronix Solutions LLC (US), SOOIL Development Co., Ltd (South Korea), Shenzhen MedRena Biotech Co., Ltd. (China), and CODAN Medizinische Geräte GmbH & Co KG (Germany).



Source link

You may also like

About Us

Arab Africana™ publishes and aggregates business, socio-economic, Tech and industrial news on Arab countries in Africa.

 

We provide press release distribution to media in Africa including Arab countries, the Arab world and the GCC/MENA regions. To submit a press release for distribution, contact us today.

Trending Now

Newsletter

    ArabAfricana logo-white

    Arab Africana is part of GroupWeb Media Network. ©  2024 GroupWeb Media LLC